Try our beta test site
1 study found for:    21457066 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glulisine;   Drug: Insulin lispro;   Drug: Insulin aspart

Study has passed its completion date and status has not been verified in more than two years.